Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Paweł, Rogala"'
Autor:
Piotr Rutkowski, Paweł Rogala
Publikováno v:
Expert Opinion on Pharmacotherapy. :1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::355863d9f9a32b5b136450f00740c17b
https://doi.org/10.1080/14656566.2023.2211765
https://doi.org/10.1080/14656566.2023.2211765
Autor:
Piotr Rutkowski, Bożena Romanowska-Dixon, Anna Markiewicz, Krzysztof Zieniewicz, Katarzyna Kozak, Paweł Rogala, Tomasz Świtaj, Monika Dudzisz-Sledź
Publikováno v:
Nowotwory. Journal of Oncology. 72:342-352
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::715f17f146c1c841992054bfaf677a0e
https://doi.org/10.5603/njo.2022.0054
https://doi.org/10.5603/njo.2022.0054
Autor:
Bożena Cybulska-Stopa, Barbara Ziółkowska, Łukasz Galus, Tomasz Kubiatowski, Stanisław Kieszko, Karolina Piejko, Jacek Mackiewicz, Piotr Rutkowski, Anna Drosik-Kwaśniewska, Jacek Calik, Grażyna Kamińska-Winciorek, Marcin Ziętek, Anna M. Czarnecka, Renata Pacholczak-Madej, Paweł Rogala, Katarzyna Gajewska-Wicher, Rafał Suwiński, Janusz Rolski, Agata Sałek-Zań, Natasza Kempa-Kamińska
Publikováno v:
Immunotherapy. 13:297-307
Aim: To evaluate treatment results in advanced/metastatic melanoma patients treated with anti-PD-1 immunotherapy in routine practice in oncology centers in Poland. Methods: Multicenter retrospective analysis included 499 patients with unresectable/me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75481f1f9c5cc0cca549a49f8bad084d
https://doi.org/10.2217/imt-2020-0217
https://doi.org/10.2217/imt-2020-0217
Autor:
Paweł Teterycz, Paulina Jagodzińska-Mucha, Tomasz Świtaj, Piotr Rutkowski, Paweł Rogala, Hanna Koseła-Paterczyk, Katarzyna Kozak
Publikováno v:
Oncology in Clinical Practice. 16:109-115
Introduction. Combined inhibition of BRAF and MEK improved progression-free survival and overall survival in patients with BRAFV600-mutation-positive metastatic melanoma. We conducted a retrospective study on real-life patients with BRAF-mutant melan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a90ce9e7b70a9c19efe1da2ae6d79ba3
https://doi.org/10.5603/ocp.2020.0017
https://doi.org/10.5603/ocp.2020.0017
Autor:
Piotr Rutkowski, Paweł Rogala, Magdalena Wiśniewska, Anna M. Czarnecka, Adrianna Gęga-Czarnota, Bożena Cybulska-Stopa, Łukasz Galus, Tomasz Kubiatowski, Paweł Teterycz, Marcin Rajczykowski, Jacek Mackiewicz, Marek Ziobro, Robert Dziura, Rafał Suwiński
Publikováno v:
Melanoma Research. 30:465-471
Despite considerable progress made in the treatment of patients with advanced melanoma, the majority of the patients treated with BRAF and mitogen-activated protein inhibitors (BRAFi and MEKi) experience a disease progression due to acquired resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8926c33a75ea08f76d9b5656c058b61a
https://doi.org/10.1097/cmr.0000000000000662
https://doi.org/10.1097/cmr.0000000000000662
Publikováno v:
Critical Reviews in Analytical Chemistry. 51:299-311
This work presents a literature review concerning the construction, properties and application of different sensors used to detect dimethyl methylphonate (DMMP), which is the simulant of sarin. Sensors sensitive to mass are described, together with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ead91253dcee33681a5e7dfb680eec3
https://doi.org/10.1080/10408347.2020.1723401
https://doi.org/10.1080/10408347.2020.1723401
Autor:
Paweł Sobczuk, Katarzyna Kozak, Sylwia Kopeć, Paweł Rogala, Tomasz Świtaj, Hanna Koseła-Paterczyk, Aleksandra Gos, Andrzej Tysarowski, Piotr Rutkowski
Publikováno v:
Cancers; Volume 14; Issue 3; Pages: 777
Cancers, Vol 14, Iss 777, p 777 (2022)
Cancers, Vol 14, Iss 777, p 777 (2022)
Assessment of BRAF mutation status is mandatory in advanced, treatment-naïve melanoma patients. Liquid biopsy can be an alternative in cases with inadequate or unavailable tumor tissue. The aim of our study was to evaluate the clinical utility of pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cee3b8afb93678ecc7b0849510d61ab
Autor:
Anna M. Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, Anna Szumera-Ciećkiewicz, Katarzyna Kozak, Tomasz Świtaj, Paweł Rogala, Iwona Kalinowska, Hanna Koseła-Paterczyk, Konrad Zaborowski, Paweł Teterycz, Andrzej Tysarowski, Donata Makuła, Piotr Rutkowski
Publikováno v:
Cancers; Volume 14; Issue 1; Pages: 110
Cancers, Vol 14, Iss 110, p 110 (2022)
Cancers
Cancers, Vol 14, Iss 110, p 110 (2022)
Cancers
Simple Summary Neoadjuvant therapy for locally advanced disease or potentially resectable metastatic melanoma is expected to improve operability and clinical outcomes over upfront surgery. 46 patients were treated with BRAFi/MEKi or BRAFi before surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320e5dab6340d6b4bfe196f6bc8e85b1
Publikováno v:
Polish archives of internal medicine. 132(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72cbf5fb646efda2da22157b3909ce71
https://pubmed.ncbi.nlm.nih.gov/34935327
https://pubmed.ncbi.nlm.nih.gov/34935327
Autor:
Paweł, Sobczuk, Katarzyna, Kozak, Sylwia, Kopeć, Paweł, Rogala, Tomasz, Świtaj, Hanna, Koseła-Paterczyk, Aleksandra, Gos, Andrzej, Tysarowski, Piotr, Rutkowski
Publikováno v:
Cancers. 14(3)
Assessment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f63a9669eda538a8bb8ae4a5466aa22f
https://pubmed.ncbi.nlm.nih.gov/35159044
https://pubmed.ncbi.nlm.nih.gov/35159044